Janet Dillione, Director at CorMedix Inc. (CRMD), bought 4,143 shares on 2016-11-14, disclosed to the SEC on 2016-11-16.
Open-market purchase of $0 CRMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CRMD | SELL | 2025-12-04 | $467K | — | Filing → |
| CRMD | SELL | 2025-11-26 | $523K | — | Filing → |
| CRMD | SELL | 2025-11-18 | $343K | — | Filing → |